Almotriptan: a balanced approach to migraine.
Effective acute treatment of migraine is possible with the 4HT(1B/1D) agonists (triptans), but their use has been limited in the UK because of concerns about limited efficacy, recurrence of attacks, adverse events, and cost.  Almotriptan (Almogran, Lundbeck Ltd, Milton Keynes), the most recently available member of the class, offers some advantages over previously available agents.
Cull
R
R
Head Clinic, Western General Hospital, Edinburgh EH4 2XU.
D003362:Cost-Benefit Analysis; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007211:Indoles / Q000191:economics / Q000627:therapeutic use*; D008297:Male; D008881:Migraine Disorders / Q000188:drug therapy* / Q000191:economics; D017366:Serotonin Receptor Agonists / Q000191:economics / Q000627:therapeutic use*; D016896:Treatment Outcome; D014363:Tryptamines
D007211:Indoles; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; C409045:almotriptan